- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04056260
ICG-NIR Guided Lymph Node Dissection in Gastric Cancer
March 19, 2020 updated by: Ho Seok Seo
Oncologic Safety of Sentinel Lymph Node-guided Lymph Node Dissection Using ICG-NIR Laparoscopy in Gastric Cancer
As the survival rate of patients with gastric cancer has increased, there has been a growing interest in interventions that improve postoperative quality of life.
Therefore minimally invasive surgery or endoscopic resection has been performed much more frequently.
However, adequate lymph node dissection is important as well.
The aim of the study is to identify the feasibility of indocyanine green - near infra-red (ICG-NIR) guided sentinel lymph node dissection for the treatment of gastric cancer.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
219
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- dignosed gastric adenocarcinoma
- tumor: size 4cm or smaller
- depth of invasion: mucosa, submucosa, proper muscle
- candidates of laparoscopic radical gastrectomy
- informed consent
Exclusion Criteria:
- metachronous malignancy
- number of tumors: 2 or more
- remnant gastric cancer
- indication for endoscopic resection
- history of chemotherapy or radiation therapy
- pregnancy
- allergy to ICG
- metastatic gastric cancer
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: ICG injection
ICG 0.5mg/ml x 0.5ml x 4 sites
|
ICG 0.5mg/ml x 0.5ml x 4 sites injection through intra-operative endoscopy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
sensitivity and specificity
Time Frame: 1 month
|
sensitivity and specificity of ICG-NIR guided lymph node dissection
|
1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
March 20, 2020
Primary Completion (Anticipated)
August 31, 2020
Study Completion (Anticipated)
December 31, 2020
Study Registration Dates
First Submitted
August 11, 2019
First Submitted That Met QC Criteria
August 13, 2019
First Posted (Actual)
August 14, 2019
Study Record Updates
Last Update Posted (Actual)
March 20, 2020
Last Update Submitted That Met QC Criteria
March 19, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SDR-01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stomach Neoplasm
-
Soonchunhyang University HospitalCompletedMalignant Neoplasm of Stomach | Benign Neoplasm of StomachKorea, Republic of
-
Jian-Kun HuRecruitingMetastases, Neoplasm | Neoplasm Seeding | Neoplasm, StomachChina
-
Fujian Cancer HospitalCompletedMalignant Neoplasm of Stomach Stage IVChina
-
Fujian Cancer HospitalUnknownClinical Trial of Apatinib Reverses Chemotherapy-Resistance of Patients With Advanced Gastric CancerMalignant Neoplasm of Stomach Stage IIChina
-
Hôpital Edouard HerriotCompletedStomach Neoplasm | Rectal Neoplasm | Intestinal NeoplasmFrance
-
European Organisation for Research and Treatment...Active, not recruitingMalignant Neoplasm of Stomach | Malignant Neoplasm of Cardio-esophageal Junction of Stomach | Epidermal Growth Factor Receptor (EGFR) Protein OverexpressionSpain, Korea, Republic of, Singapore, Switzerland, Germany, United Kingdom, Italy, France, Estonia, Belgium, Netherlands, Norway, Portugal
-
Elevation OncologyRecruitingNeoplasms | Neoplasms by Site | Gastrointestinal Neoplasms | Digestive System Neoplasm | Pancreas Neoplasm | Stomach NeoplasmUnited States, Japan
-
Fox Chase Cancer CenterRecruitingMalignant Neoplasm of Stomach | Neoplasm - Soft Tissue Pelvis Malignant SecondaryUnited States
-
Charite University, Berlin, GermanyCompletedNeoplasm Metastasis | Stomach NeoplasmGermany
-
Charite University, Berlin, GermanyCompletedNeoplasm Metastasis | Stomach NeoplasmGermany
Clinical Trials on ICG-NIR guided surgery
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingGynecologic SurgeryUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedSuspected Central Nervous System TumorsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); University of TexasCompleted
-
Massachusetts General HospitalBrigham and Women's Hospital; Society of University SurgeonsRecruiting
-
Niguarda HospitalRecruiting
-
University Health Network, TorontoCompletedHead and Neck NeoplasmsCanada
-
IsalaArthrex, Inc.; Diagnostic Green GmbHNot yet recruitingMeniscus Rupture
-
Beijing Tiantan HospitalPeking Union Medical College Hospital; Chinese Academy of Sciences; National...Unknown
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...RecruitingRectal Cancer | Lymph Node Cancer MetastaticItaly
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical CenterCompleted